Ryan Sartor, MD
Gastroenterology · Chapel Hill, NCNPI 1922169051
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $12,891 of the $13,086 with a category attached, or 98.5%. Takeda Pharmaceuticals U.S.A., Inc. accounts for 73.7% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2020 at $9,090 and has fallen 98.5% since, to $138 in 2024.
Across 10 payments — averaging $1308.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$10K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$3K
- Janssen Scientific Affairs, LLC$116
- Janssen Research & Development, LLC$42
- Ferring Pharmaceuticals Inc.$22
- AbbVie$15
Across 8 payments — averaging $83,380 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$427K
- Takeda Pharmaceuticals U.S.A., Inc.$232K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$9K
What the payments were for
- Consulting fees$12,89199%
- Food & beverage$1951%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $9,639 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $3,252 |
| Janssen Scientific Affairs, LLC | 1 | $116 |
| Janssen Research & Development, LLC | 2 | $42 |
| Ferring Pharmaceuticals Inc. | 1 | $22 |
| AbbVie | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- STELARA$116
How this compares
$13,086 in reported general payments places this provider in the 85th percentile of 610 gastroenterology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gastroenterology in Chapel Hill
- Paul WatkinsChapel Hill$876K
- Evan DellonChapel Hill$431K
- Alfred BarrittChapel Hill$210K
- Nicholas ShaheenChapel Hill$145K
- Christine HuntChapel Hill$122K
- Hans HerfarthChapel Hill$78K
- Simon GrayChapel Hill$48K
- Jasmine BarrowChapel Hill$22K
- Stephen DealCharlotte$945K
- Fred FowlerCharlotte$932K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.